Long-Term Safety and Efficacy of Tralokinumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis Treated for up to 6 Years. J of Skin. 2025;9(2):s573. doi:10.25251/skin.10.supp.573